Remove 2012 Remove Marketing Remove Pricing Remove Study
article thumbnail

Entrepreneur Association Conference

SoCal Tech Calendar

Friday, May 11, 2012 -- Entrepreneur Association Conference. 15 percent discount for SOCALTECH readers. 15 percent discount for SOCALTECH readers. Use promo code: SOCALTECH. See [link] (more)

article thumbnail

Why Entrepreneurs Hate (Most) MBAs

InfoChachkie

Tool Users - Startups often have a long gestation period in which the team is in discovery mode, defining the company's value proposition, target market, pricing, business model, etc. Unfortunately, the 2012 QS TopMBA.com Applicant Survey notes that, on average, MBAs expect to earn $153,000 upon graduation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Competitive Intelligence

SoCal Tech Calendar

Tuesday, March 20, 2012 -- Competitive Intelligence: 007 Market Intel. Your mission, should you choose to accept it, is to estimate market size, competitive market share, how many potential customers are there, and price points. Just who is doing what in the market? PDMA SoCal. It's Monday morning.

article thumbnail

Business 2011 - Optimism, But Heed the Lessons

Startup Professionals Musings

Just yesterday, a new study “ The PNC Economic Outlook: Survey of Small & Middle-Market Business Owners ” was published. Add new revenue streams, and more aggressive marketing. At the same time, 62% plan to invest more in marketing and advertising, while 50% will invest in expansion and 46% will pursue new revenue streams.

Study 89
article thumbnail

8th Talk at USC Marshall School: How My Failure at Make It Work can Benefit Geek Squad and Best Buy

Eric Greenspan

I had suppressed much of what happened prior to and after that day, June 25, 2012. In 2010, after my 5th talk, USC Marshall School produced a case study about the customer centricity offered by the company. I’m not certain it’s a profitable market however. It’s been 10 months and I really need to move on.

USC 157
article thumbnail

Evoke Pharma’s Stock Sinks on Stomach Drug’s Phase 3 Failure

Xconomy

Evoke Pharma is taking a hit in the markets after announcing a Phase 3 trial on a gastroinetestinal drug for diabetes patients failed to meet its goals. In early trading Monday, Evoke’s (NASDAQ: EVOK ) stock price was down 72 percent to $3.02 per share as of 11:30 a.m. in New York. Evoke didn’t reveal any further plans.

Study 40
article thumbnail

The Future of Couponing | How Social-Local-Mobile has Changed the Game

Tech Zulu Event

Due to the combination of these factors, marketers began to more heavily fund digital platforms. Daily deal” couponing continues to be a popular tool among consumers and marketers, and many major companies have implementing their own version of the trend. A study conducted by Rice University’s Jesse H.

Mobile 85